Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source
Transfusion
.
2023 Jun;63(6):1255-1256.
doi: 10.1111/trf.17335.
Authors
Rugved Pattarkine
1
,
Aida-Rae Manansala
1
,
Alyssa Ziman
1
,
Dawn C Ward
1
Affiliation
1
Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
PMID:
36971055
DOI:
10.1111/trf.17335
No abstract available
Publication types
Letter
MeSH terms
Blood Component Removal*
Factor VIII / therapeutic use
Fibrinogen / therapeutic use
Humans
Plasma
Substances
Factor VIII
Fibrinogen